ATE140972T1 - Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog - Google Patents

Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog

Info

Publication number: ATE140972T1
Authority: AT; Austria
Prior art keywords: fusion proteins; tratp; pct; proteins consisting; lhrh analog
Prior art date: 1989-08-25

Application number

AT90912564T

Other languages

English (en)

Inventor

Gregory John Russell-Jones

Andrew George Stewart

Con George Tsonis

Original Assignee

Biotech Australia Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-08-25

Filing date

1990-08-24

Publication date

1996-08-15

1990-08-24 Application filed by Biotech Australia Pty Ltd filed Critical Biotech Australia Pty Ltd

1996-08-15 Application granted granted Critical

1996-08-15 Publication of ATE140972T1 publication Critical patent/ATE140972T1/de

Links

102000037865 fusion proteins Human genes 0.000 title abstract 6
108020001507 fusion proteins Proteins 0.000 title abstract 6
XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical class C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 title abstract 2
239000002434 gonadorelin derivative Substances 0.000 title 1
241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
230000001850 reproductive effect Effects 0.000 abstract 2
229960005486 vaccine Drugs 0.000 abstract 2
230000002401 inhibitory effect Effects 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
102000040430 polynucleotide Human genes 0.000 abstract 1
108091033319 polynucleotide Proteins 0.000 abstract 1
239000002157 polynucleotide Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

AT90912564T 1989-08-25 1990-08-24 Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog ATE140972T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPJ597989		1989-08-25

Publications (1)

Publication Number	Publication Date
ATE140972T1 true ATE140972T1 (de)	1996-08-15

Family

ID=3774139

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90912564T ATE140972T1 (de)	1989-08-25	1990-08-24	Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog

Country Status (7)

Country	Link
US (1)	US5403586A (de)
EP (1)	EP0446313B1 (de)
AT (1)	ATE140972T1 (de)
CA (1)	CA2040441C (de)
DE (1)	DE69027983T2 (de)
NZ (1)	NZ235038A (de)
WO (1)	WO1991002799A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5484592A (en) *	1989-03-23	1996-01-16	Stitching Centraal Diergeneeskundig Instituut	Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs
WO1992005192A1 (en) *	1990-09-18	1992-04-02	Biotech Australia Pty. Limited	T-cell epitopes
US5723129A (en) *	1991-10-16	1998-03-03	University Of Saskatchewan	GnRH-leukotoxin chimeras
US5837268A (en) *	1991-10-16	1998-11-17	University Of Saskatchewan	GnRH-leukotoxin chimeras
EP0618813B1 (de) *	1992-09-16	2002-01-09	The University Of Tennessee Research Corporation	Antigene des hybriden m-proteins und träger für gruppe a streptokokkenimpfstoff
US5688506A (en)	1994-01-27	1997-11-18	Aphton Corp.	Immunogens against gonadotropin releasing hormone
AUPO776897A0 (en) *	1997-07-09	1997-07-31	Csl Limited	A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) *	1999-01-08	1999-02-04	Csl Limited	Improved immunogenic lhrh composition and methods relating thereto
ATE286511T1 (de) *	1999-02-17	2005-01-15	Pfizer Prod Inc	Fusionsproteine mit trägern welche eine doppelte immunantwort induzieren
US6838553B1 (en) *	1999-10-05	2005-01-04	Academia Sinica	Peptide repeat immunogens
US6783761B2 (en)	2000-05-05	2004-08-31	Aphton Corporation	Chimeric peptide immunogens
CA2736604C (en)	2008-09-17	2017-01-03	Charles Rupprecht	Rabies virus-based recombinant immunocontraceptive compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4624926A (en) *	1981-01-02	1986-11-25	The Research Foundation Of State University Of New York	Novel cloning vehicles for polypeptide expression in microbial hosts
DK582381A (da) *	1981-01-02	1982-07-03	Univ New York	Remkombinat plasmid til anvendelse ved bakteriel kloning
AU619443B2 (en) *	1986-04-21	1992-01-30	Bioenterprises Pty. Ltd.	Immunopotentiation
CA1331355C (en) *	1986-04-21	1994-08-09	Bioenterprises Pty. Ltd	Immunopotentation
NZ220932A (en) *	1986-07-03	1990-05-28	Victoria State	Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
AU7642387A (en) *	1986-07-03	1988-01-29	State Of Victoria, The	Composition and method for immunological castration and spaying
WO1988005308A1 (en) *	1987-01-14	1988-07-28	Commonwealth Scientific And Industrial Research Or	Anti reproductive hormone
GB8713240D0 (en) *	1987-06-05	1987-07-08	Proteus Biotech Ltd	Hormones

1990
- 1990-08-24 AT AT90912564T patent/ATE140972T1/de not_active IP Right Cessation
- 1990-08-24 NZ NZ235038A patent/NZ235038A/en unknown
- 1990-08-24 US US07/690,983 patent/US5403586A/en not_active Expired - Fee Related
- 1990-08-24 WO PCT/AU1990/000373 patent/WO1991002799A1/en not_active Ceased
- 1990-08-24 DE DE69027983T patent/DE69027983T2/de not_active Expired - Fee Related
- 1990-08-24 EP EP90912564A patent/EP0446313B1/de not_active Expired - Lifetime
- 1990-08-24 CA CA002040441A patent/CA2040441C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NZ235038A (en)	1992-09-25
EP0446313A4 (en)	1992-08-19
WO1991002799A1 (en)	1991-03-07
CA2040441C (en)	1998-03-31
EP0446313B1 (de)	1996-07-31
CA2040441A1 (en)	1991-02-26
US5403586A (en)	1995-04-04
DE69027983T2 (de)	1997-03-20
DE69027983D1 (de)	1996-09-05
EP0446313A1 (de)	1991-09-18

Legal Events

Date	Code	Title	Description
1997-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
AU655915B2 (en)	1995-01-19	Cosmetic deodorants
DE69027983D1 (de)	1996-09-05	Fusionsproteine bestehend aus TraTp und mindestens einem LHRH-Analog
DE69334266D1 (de)	2009-04-23	Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate
DE69433530D1 (de)	2004-03-11	Bmp-11 zusammensetzungen
DK0397633T3 (da)	1996-01-02	Fibronectinbindende protein samt fremstilling deraf
BR9305617A (pt)	1996-01-09	Uso de isolados de bacillus thuringiensis para controlar pragas na familia dos afidideos
NO892033D0 (no)	1989-05-19	Fibronectinbindende protein.
NO882380L (no)	1988-12-02	Fibfonektin-bindende protein, samt fremstilling derav.
DK525384D0 (da)	1984-11-05	Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
AU6070390A (en)	1991-02-22	Compositions derived from bi4v2o11
DE69010294D1 (de)	1994-08-04	Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ATE190318T1 (de)	2000-03-15	Pcna bindende substanz
ATE155008T1 (de)	1997-07-15	Neue bacillus-thuringiensis isolate zur bekämpfung von akariden
DE59206628D1 (en)	1996-07-25	Expression signalpeptid-freier staphylokinasen
SE8801723D0 (sv)	1988-05-06	Fibronectin binding protein as well as its preparation
DE3853383D1 (de)	1995-04-27	Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.
ATE148744T1 (de)	1997-02-15	Neue thrombininhibitorische proteine aus landblutegeln
ES2059801T3 (es)	1994-11-16	Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
AU643773B2 (en)	1993-11-25	Growth hormone releasing factor analogs